Table of Contents

Welcome Letter...... page 4

Unity Sponsors...... page 8

ASA Board of Directors...... page 11

ASA Staff...... page 12

Agenda...... page 15

Speaker Biographies...... page 19

Save the Date! ASA 2021 Information...... page 28 6th: Absolute cleanliness is Godliness! Balanced food for body-mind-soul-spirit is our medicine! Full truth our God, half-truth our enemy, hard work our salvation, unity our goal, Free Speech our weapon, All-One our soul, self-discipline the key to fr eedom,

All-One!!! unit y, unite l ove help

unites o, S e! All-One wledg kno ab ov e! to y ke F or the we is ’r e All-One! epetition R As ools! f t each f or andering 6, w 000 e ’r we ye or

ar s astr onomer mankind, unite s Abr Help aham last! & n’t Isr wo ael: “€‚ƒ „ † ‡ˆ‚€‰Š † disappointments , past „ Š†‹€ the of out Œ eep ‹ k „ˆ Š , els „ Š†‹€€ jew en giv

re Ž a ‘† ’” arless fe E xc the

ep To tions Eternally rthwhile! wo ? ays Absolute alw is e lif , None!!! smile a S o, with when orld w y our the f ce ello

Fa GOOD FOR YOU AND SPACESHIP EARTH. w man All-One! y ou One! measur e, Uniting t ak ee! fr e him at mankind his

all FAMILY SOAPMAKERS SINCE 1858 MUCH LOVED FOR GOOD REASON best:

True to the vision of Dr. E.H. Bronner and Cleanliness is Godliness! 18 uses in 1 mild with -l ov e-unite

157 years of soapmaking tradition: Work yet mighty soap. Eective, ecological, that ork w hard! Improve! Make the best better! versatile–vegan and cruelty-free. Certi- le ve to w r,

Seek the purest, most eective organic ‹ed Fair Trade ingredients, made with lift ho

and fair trade ingredients, like hemp oil organic oils, no harsh synthetics. 100% him enemy 100% higher & for a soft, smooth lather that won’t dry biodegradable in a post-consumer

Available in Eucalyptus, Rose, Tea Tree, Citrus Orange, Almond, Baby Unscented, Peppermint and Lavender

your skin. Body, hair, face, mouth & teeth – recycled bottle. Enjoy only 2 cosmetics, ,

ov erlook friend food, dishes, laundry, mopping, pets – Dr. enough sleep & Dr. Bronner’s Magic Soaps DR. BRONNER’S In all we do, let us be generous, teach Bronner’s is the very best soap for hu- to clean body-mind-soul-spirit instantly fair & loving to Spaceship Earth IS CERTIFIED and all its inhabitants. For we’re the Then

man, home and Earth. Dilute! Dilute! OK! uniting One! For we’re All-One or None! CONTAINS AT LEAST 70% FAIR TRADE INGREDIENTS  FAIR FOR LIFE CERTIFIED BY IMO -   - re st

!

done! h 7t Get Get d! har ork w , time a at thing one Do ead! d ’s He ault? f without man the Find ahead! ears y 10 act & Think friend. my , smile & e ag our c ve Ha hate! -true half no e, -mat r ove -l -teacher ainer -tr -builder vider o -pr pilot ect perf a be to d har s ork w swallow Each : Welcome Letter

Welcome to Unity 2020!

Thank you for joining us from your home. I hope that you are safe and healthy. We learn a lot about what is important during times like these and as I write this I am overwhelmed with gratitude for the long lasting friendships I have made on my journey with Americans for Safe Access. A journey that started almost two decades ago.

Through our work we have changed the social fabric of not just our society but the global perspective on medicine. As a point in case, last Monday, March 16th, ASA sent out a letter to call on governors and directors of state medical cannabis programs to take immediate action to ensure that patients continue to have access to medical cannabis and that the supply chain is not interrupted while Governors are creating emergency plans in their states to address the COVID-19 pandemic. We are happy to announce that as of today, 18 of the 33 states with medical cannabis laws have deemed medical cannabis business “essential” alongside pharmacies and hospitals with more to come. This is heart-warming not only because it is a sign that our decades of struggle are being realized but also because, ASA, the organization we built together, and all of you, were ready to jump into action during the COVID-19 pandemic to make sure medical cannabis patients were not forgotten.

As we move into a new decade, it is incredible to see how much has changed just in the last 10 years. On January, 1, 2010 there were only 13 states with medical cannabis programs. Today, 33 states, the District of Columbia, Guam, the Commonwealth of the Northern Mariana Islands, the U.S. Virgin Islands, and Puerto Rico have adopted laws creating programs that allow at least some patients legal access to medical cannabis. Across the country, there are 3 million medical cannabis patients, and 91% percent of Americans now live in states with some form of access to medical cannabis.

In the last decade alone, cannabis has become a more popularized form of medicine than ever before; a CBS News poll of doctors showed that 88% of doctors were in favor of recommending cannabis as a treatment to patients. Doctors aren’t the only ones taking note, legislators have found medical cannabis programs to be one of the most popular policy platforms; a random sampling of Americans polled by Quinnipiac in 2018 responded 94% in favor when asked if they supported legal access to medical cannabis with a doctor’s recommendation. Welcome Letter

However, despite all these advancements, cannabis retains its Schedule I status under the Controlled Substances Act, meaning the federal government still considers it to be a dangerous, highly addictive substance with no medical value. This continues to cause numerous conflicts between the federal government and the states that have enacted these programs.

With 2020 being an election year, it is more important than ever this year to focus on patient issues and to let Congressional members know that your vote for them depends on their stance on medical cannabis. While it often seems like national legalization is right around the corner, we know that legalization alone will not guarantee access to all the patients that could benefit from this medicine, nor will it advance important issues like medical professional education or insurance. It is important to remember that despite all of the advances in medical cannabis across the states, half or more of these populations are left out of the programs because of financial, legislative, and regulatory barriers.

Countries around the world are making reforms to get their citizens safe and affordable access to medical cannabis- regulated by a federal office- putting into place minimum standards for labeling and packaging, standards for cultivation, and standards for testing for pesticides, heavy metals, contaminants, adulterants, and other potential threats to health. American patients should expect the same.

For this reason, last year ASA unveiled its new legislation that explores how to end this conflict through the creation of a new federal agency, the Office of Medical Cannabis Control (OMCC). As it stands, nearly a dozen different federal agencies from the DEA to the USDA play a role in regulating cannabis. Our plan seeks to consolidate their authority in the OMCC and calls for the descheduling of cannabis (or, failing that, the rescheduling of cannabis to a new Schedule V(A) that would allow for cannabis to be used as a frontline medication. This action would end the conflict between states and the federal government on cannabis policy. This year our priority is to bring the idea of a national regulatory framework for medical cannabis into the national conversation. Welcome Letter

I am honored to know that ASA has played a critical role in many of the incredible advancements in medical cannabis policy across the U.S. and globally throughout our 18 years. ASA’s role as a thought leader in the field of medical cannabis has led to the legal and regulatory framework that has shaped the medical cannabis industry we see today. Driven by a commitment to patient advocacy, ASA will continue focusing on federal legislative strategies to expand access across the nation; this also means setting standards and expectations for the industry serving patients.

It has been my honor to serve as ASA’s President and Founder for the last 18 years. As our community has grown and our voice has strengthened, it brings me great pride to see that ASA’s programs and projects have become pillars to the medical cannabis movement. Thank you for joining us this year and as the fight for safe access continues, I look forward to you being a part of our success of greater patient access.

Sincerely,

Steph Sherer Founder and President Americans for Safe Access ad 3 DRIVE THE CANNABIS MOVEMENT Secure Fair Access and Social Justice

wmpolicy.com Thanks to Our Unity Sponsors! Diamond

Titanium

Sapphire

Gold Thanks to Our Unity Sponsors! Silver

Bronze

Media Partners Patient Sponsor YOUR MEDICINE aura SHOULDN’T MAKE REDUCES PATIENT YOU SICK. SIDE EFFECTS WITH ARTIFICIAL

ad 2 INTELLIGENCE

WHY SHOULD YOU JOIN THE https:/ / research.aureliusdata.com / aura RESEARCH PLATFORM? PRECISION MEDICINE

Because we believe certain Our drug, and disease speci�ic pro�iles will identify contraindications, reveal side effects and highlight cannabinoid compounds have the negative impacts. Our AI and deep learning will create unique pro�iles and precision solutions. potential to replace up to 40% AGNOSTIC ANALYSIS of traditional pharmaceuticals. organizations,.We have large medical pools of MSOs, users syndicatedthrough of�icial data com- data sharing partnerships with cannabis advocacy

panies, POS Operators, dispensaries, market research �irms, manufacturers and cultivators. doctorsWe �ill desperately the gaps for need. patient usage, dosage, population indication, form factor and application that providers and CREATIVE COLLABORATION

We signi�icantly mitigate risk for the entire supply chain. The supplementsOur data will andallow nutraceuticals. us to create novel combination therapies between cannabis, food and beverage, negativemarket is product already use promoting and consumer incomplete sentiment data; insightsAurelius . not only �ills in the gaps, but exposes the extremely important We improve care outcomes, reduce regulatory and legal exposure, ETHICALLY DRIVEN & decrease healthcare expenditures. We turn the data rich, insight plat- poor healthcare ecosystem that exists today, into insights. aura We reduce harm by mitigating risk. The Our management and development teams can create form (100,000 medical cases expected by 2021) feeds information into the AI data ecosystem tech, data, medical, CPG, and pharmaceutical industries. through natural language & biometric inputs, opti- meaningful tools that put patients �irst, with years in the symptomcal scansEMAIL ofcorrelations. products, and is backed with scienti�ic product analysis, yielding direct cannabinoid, to LINKEDIN Our business and medical advisory boards include industry @aurelius-data-inc leading doctors, medical researchers, SV Tech leaders, US Ambassadors and activists and advocates. INVESTORS.AURELIUSDATA.COM ASA Board of Directors

Steph Sherer Founder & President

Ben Bronfman Don Duncan Nic Easley

Jayan Fazal-Karim Antonio Frazier Pavel Kubu

Dr. Carla Rossotti Mary Shapiro Nick Ventura Vázquez ASA Staff

Debbie Churgai, MA Interim Director [email protected]

Reenal Doshi, MPH Heather Despres, MSc Geoffrey Marshall Director of Outreach Patient Focused Office & Membership and Certification Director Coordinator Communications [email protected] [email protected] [email protected]

Andrew Coon Sean Khalepari, MA Wiliam Dolphin Associate Policy Regulatory Affairs Publications Coordinator Coordinator [email protected] [email protected] [email protected] ad 4 Agenda

All Times Listed Are Eastern Time

12:00PM–12:45PM Welcome and Agenda Overview

Steph Sherer, Americans for Safe Access Debbie Churgai, Americans for Safe Access

1:00PM–2:00PM No Patient Left Behind: Transitioning State Programs and The Campaign for Patients As states continue their efforts towards greater access of cannabis and can nabis products in the market, a new problem has arisen. How do states transition from medical to recreational or CBD-only to medical and ensure that patients are still prioritized in terms of access and quality of product?

Ngiste Abebe, Columbia Care Nichole Snow, MA Patient Advocacy Alliance Christine Stenquist, TRUCE Moderator: Debbie Churgai, Americans for Safe Access

2:15PM–3:30PM Lessons to be Learned: International Landscape and How It Can Shape US Policy As the US continues a state-by-state approach towards regulating cannabis and cannabis products, countries around the world are leading by example in their implementation efforts. What are the challenges and best practices that we can learn from these countries as the US legislative and regulatory scene continues to push forward both federally and locally?

Nic Easley, 3C Cannabis Consulting Michael Krawitz, Veterans for Medical Cannabis Access Hilary Black, Canopy Growth Pavel Pachta, International Cannabis and Cannabinoids Institute Moderator: Steph Sherer, Americans for Safe Access

Agenda

All Times Listed Are Eastern Time

3:45PM–4:45PM Safety First: How Science & Research Can Impact Patient Safety Developments in research and science continue to show new reasons why cannabis is a viable, safe product for a variety of ailments. Hear from leading experts about what they are working on and what discoveries have added to the argument for a cannabis accessible country.

Josh Crossney, Cannabis Science Conference Antonio Frazier, CannaSafe Moderator: Heather Despres, Americans for Safe Access

5:00PM–5:45PM ASA’s 2020 Advocacy and Legislative Priorities The core ASA value has always been advocacy, although we can not lobby together this year, we want to take this time to talk about our efforts at the state and federal level. During this time ASA staff will talk about the importance of advocacy at the state level, as well as go over our new Office of Medical Canna bis Control legislation and other federal bills from our Lobby from Home Action Alert.

Don Duncan, Americans for Safe Access Steph Sherer, Americans for Safe Access Moderator: Debbie Churgai, Americans for Safe Access

5:45PM–6:00PM Closing Statement from the Executive Office

Debbie Churgai, Americans for Safe Access Steph Sherer, Americans for Safe Access PATIENTS: USE CODE MED50 FOR 50% OFF ALL CONFERENCE TICKETS

BALTIMORE, MD th st JOIN US!!! JUNE 29 – July 1 , 2020 BALTIMORE CONVENTION CENTER 2,500+ Attendees Analytical, Medical, Cultivation & Hemp Tracks! The World’s Largest and Most Attend Canna Boot Camp! Technical Cannabis Science Event! Build Brand Awareness Share Information Network & Learn

Hosted by Joshua Crossney & Andrea Peraza (CSC Events, LLC) Sponsorship and exhibition opportunities available. Contact [email protected]

CANNA BOOT CAMP CANNABIS EXPERTS EXCITING EXHIBIT FLOOR POSTER SESSIONS

INTERACTIVE PANELS NETWORKING MIXERS CULTIVATION EXPERTS MEDICAL EXPERTS

CannabisScienceConference.com             

    Speakers

Ngiste Abebe Director of Public Policy, Columbia Care

Ngiste is Director of Public Policy at Columbia Care, one of the nation’s leading medical cannabis companies. Prior to that, she was co-founder of Undaunted Ventures, a political consulting firm which specializes in innovative narrative, training, and leadership coaching services, and which grew out of her work training progressive organizations and working on campaigns across Virginia. Prior to that, Ngiste served with the U.S. Agency for International Development’s Office of Transition Initiatives, supporting the growth of peaceful democracies in countries emerging from conflict, including designing a program countering violent extremism for USAID/ Bosnia. In 2013, Ngiste co-authored Bidding for Development, examining how cities can benefit from failed Olympic bids. Ngiste holds a BA in Public Policy from the University of Chicago and a Masters in Public Policy and Management from Carnegie Mellon University.

Hilary Black Chief Advocacy Officer, Canopy Growth

In her role as Chief Advocacy Officer at Canopy Growth, Hilary Black is responsible for driving patient advocacy efforts worldwide, executing the Company’s social purpose strategy including social justice initiatives, and co-leading the implementation of best practices for diversity & inclusion.

She championed an initiative focusing on the role of cannabis in addressing the opioid overdose crisis and other substance use disorders. She regularly consults with various government bodies, providing assistance with navigating and shaping legalization related to cannabis.

In 1997, Hilary founded the British Columbia Compassion Club Society (BCCCS), the first medical cannabis dispensary in Canada. In addition to providing medical cannabis therapies, the BCCCS offers subsidized natu- ral healthcare services in its Wellness Centre, dramatically improving the health and quality of life for thousands of critically and chronically ill Cana- dians. Speakers

Joshua Crossney President, Founder & CEO, CSC Events, LLC Joshua Crossney is the President, CEO & Founder of CSC Events, LLC., which hosts and operates the world’s largest scientific and medical cannabis event, the semi-annual Cannabis Science Conference (www.Canna- bisScienceConference.com), including a Canna Boot Camp (a full-day, hands- on workshop that covers many aspects of cannabis science and industry). Joshua has a background in analytical science recruiting and event planning. Joshua Crossney is also the President & Founder of jCanna, Inc., (www. jCanna.com) a 501(c)3 non-profit organization devoted to the advancement of cannabis science, analytical testing, and personalized (precision) medicine.

Joshua is an Advisory Board member of CannaKids, a California Cooperative who supplies mold, pesticide and solvent free Honey Gold cannabis oil to children and adults who are suffering from cancer, autism, epilepsy, PTSD, Crohn’s disease, severe pain disorders, and so much more.

Nic Easley 3C Consulting, LLC Nic Easley is the CEO and founder of 3C Consulting, LLC™, the leading consulting firm in the global cannabis industry, providing strategic and tactical consulting to cultivation, extraction, manufacturing, retail, delivery, and distribution companies, as well as ancillary service providers and product manufacturers. Nic and the 3C team have worked in 34 U.S. States, two territories, and 17 countries, helping nearly 500 clients to design, start-up, build and scale their cannabis companies.

Over the past 11 years, Nic has developed a reputation as a globally recognized cannabis industry expert and a sought-after writer, panelist, and keynote speaker for many top conferences and publications. Nic is a Veteran of the United States Air Force and fluent in numerous languages holding degrees in both Environmental Studies and Biology. He is also a committee or board member for multiple cannabis industry organizations, including as a Board Member for Americans for Safe Access (ASA). Nic recently educat- ed delegates on medical cannabis at the UN Intergovernmental Expert Group Meeting on International Challenges Posed by the Non-Medical use of Synthetic Opioids. Speakers

Antonio Frazier VP of Operations, CannaSafe Antonio Frazier is the VP of Operations at CannaSafe, the first ISO licensed cannabis lab in the world, and the leading market shareholder in California. He met CannaSafe President Aaron Riley while playing football together at Furman University, where he earned a Bachelor of Science degree; he also holds a B.S. in Materials Engineering from Clemson. Frazier began his career as a Nuclear Quality Engineer for the Tennessee Valley Authority, certifying and verifying the final construction of nuclear components. He then moved into aerospace engineering, performing quality assurance for the foundry, testing lab, heat treat, and special finishing departments for SKF USA (Baltimore). Frazier enjoys using his industrial, public safety-focused skillset to forge the standards of a burgeoning industry; cannabis is a huge bonus. He has expanded CannaSafe’s community involvement with a heavy focus on social equity and accessible consumer safety education.

Michael Krawitz Executive Director, VCMA A disabled United States Air Force Veteran (Sergeant, 1981–1986), Michael Krawitz currently serves as executive director of Veterans for Medical Cannabis Access (VMCA), as well as holding other advisory roles. Under Michael’s leadership VMCA successfully negotiated the first ever medical cannabis policy within the VA in 2010 and has overseen a successful nationwide effort to add Post Traumatic Stress as a qualifying condition under state medical marijuana access laws. Michael helped successfully lead the NGO working group through the first ever Cannabis Critical-Review process of the World Health Organization Expert Committee on Drug Dependence. Speakers

Nichole Snow Executive Director, MPA Nichole Snow is the president and executive director of the Massachusetts Patient Advocacy Alliance and one of ten Ex-Officio Advisors to the MA Cannabis Control Commission. The MPAA works with local and state governmental bodies to ensure the social welfare of medical marijuana patients, doctors, caregivers, medical professionals, advocates, and the general public while developing and implementing laws, policies, and regulations related to medical marijuana and its safe use.

After meeting hundreds of patients across the state of Massachusetts and advocating for their right to safe access, Nichole was invited to take a leadership role in the alliance in 2014. Since becoming executive director of the fledgling organization, Nichole worked with all stakeholders involved in the implementation of the Humanitarian Care Act of 2012 to draft viable regulations, site 56 operational medical cannabis access points across the Commonwealth, grow the number of patients to more than 57,000, the number of registering clinicians to at least 300, and the number of personal caregivers to more than 7,000 in 2019. DPH has overseen the Medical Use of Marijuana Program since its launch in 2014 and was fully transitioned to the MA Cannabis Control Commission in 2018. Speakers

Christine Stenquist President & Founder, TRUCE

Christine Stenquist is a mother of four, a brain tumor survivor, and a chronic pain patient who became a cannabis advocate. In 1996, she was diagnosed with an Acoustic Neuroma, a rare benign brain tumor. An unsuccessful surgery left 60% of the tumor still intact. Due to complications during the surgery, Christine was unable to rejoin the workforce and had to file for disability.

Through her own research, she eventually tried marijuana and found that it mitigated the symptoms that had kept her trapped in stagnation for so long.

Knowing there wasn’t safe, legal access to medical cannabis in Utah, she started advocating in the state for policy change, creating and building the nonprofit organization TRUCE (Together for Responsible Use and Cannabis Education) in the process.

In 2017, after years of working to get a legislative approach enacted without success, Christine became one of the chief sponsors of the Utah Medical Cannabis Act. A year later it passed with 53% support. However, the pass- ing of the ballot measure triggered a “repeal and replace” reaction from the legislature who felt the initiative was too “recreational.”

On March 2, 2020, Utah opened its first cannabis “pharmacy”. Follow Us For more, visit @CannaSafe www.CSALabs.com

CannaSafe is an analytical “The testing laboratory committed to ensuring consumer safety and quality assurance standards pursuit for the cannabis industry. We pride ourselves in providing of safe quality, value, and integrity- based testing for safe cannabis cannabis and hemp consumption. We’re also committed to serving our and hemp community, and focus heavily on social equity and consumer for all” safety education.

© CannaSafe • [email protected] • (818) 922-2416 7027 Hayvenhurst Ave. Van Nuys, CA 91406

Reach more customers. Drive more revenue. Expand your impact.

Award-winning branding, digital marketing, and custom software solutions for businesses in the cannabis & hemp industries mindbuzz.com | [email protected] 吀栀攀 瀀爀攀挀氀椀渀椀挀愀氀Ⰰ 挀氀椀渀椀挀愀氀Ⰰ 愀渀搀 洀攀搀椀愀ⴀ爀攀瀀漀爀琀攀搀 栀甀洀愀渀 攀瘀椀搀攀渀挀攀 椀猀 挀氀攀愀爀⸀ ad 5

䌀愀渀渀愀戀椀猀 挀愀渀 昀椀最栀琀 挀愀渀挀攀爀 椀渀 愀琀 氀攀愀猀琀 猀漀洀攀 挀愀猀攀猀⸀ 䘀漀爀 琀栀椀猀 爀攀愀猀漀渀Ⰰ 挀愀渀挀攀爀 瀀愀琀椀攀渀琀猀 琀栀爀漀甀最栀漀甀琀 琀栀攀 眀漀爀氀搀 搀攀猀攀爀瘀攀 琀栀攀 爀椀最栀琀 琀漀 甀猀攀 挀愀渀渀愀戀椀猀 洀攀搀椀挀椀渀攀 椀昀 搀攀猀椀爀攀搀⸀ 嘀椀猀椀琀 䌀愀渀渀愀戀椀猀䐀攀挀氀愀爀愀琀椀漀渀⸀挀漀洀 琀漀 氀攀愀爀渀 洀漀爀攀 愀戀漀甀琀 昀愀挀椀氀椀琀愀琀椀渀最 愀挀挀攀猀猀 昀漀爀 挀愀渀挀攀爀 瀀愀琀椀攀渀琀猀⸀ ad 1/2 pg

Patients Care Collective, the oldest continuously-operating cannabis retailer in the United States, proudly supports ASA’s ongoing work to protect and expand patients’ rights.

BerkeleyPatientsCare.com Medical & Adult-Use Cannabis Ad 1 Save the Date!

ASA 2021 National Conference

May 4-6, 2021 Washington, DC

More information will be provided at www.safeaccessnow.org